au.\*:("HOPF, Carsten")
Results 1 to 5 of 5
Selection :
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsBANTSCHEFF, Marcus; EBERHARD, Dirk; READER, Valérie et al.Nature biotechnology (Print). 2007, Vol 25, Num 9, pp 1035-1044, issn 1087-0156, 10 p.Article
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesBANTSCHEFF, Marcus; HOPF, Carsten; BOESCHE, Markus et al.Nature biotechnology (Print). 2011, Vol 29, Num 3, pp 255-265, issn 1087-0156, 11 p.Article
Identification of serum proteins bound to industrial nanomaterialsRUH, Hermelindis; KÜHL, Boris; BRENNER-WEISS, Gerald et al.Toxicology letters. 2012, Vol 208, Num 1, pp 41-50, issn 0378-4274, 10 p.Article
Imaging of complex sulfatides SM3 and SB1a in mouse kidney using MALDI-TOF/TOF mass spectrometry : MALDI ImagingMARSCHING, Christian; ECKHARDT, Matthias; GRÖNE, Hermann-Josef et al.Analytical & bioanalytical chemistry (Print). 2011, Vol 401, Num 1, pp 53-64, issn 1618-2642, 12 p.Article
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaDAWSON, Mark A; PRINJHA, Rab K; HUTHMACHER, Carola et al.Nature (London). 2011, Vol 478, Num 7370, pp 529-533, issn 0028-0836, 5 p.Article